# VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers

> **NCT03332732** · PHASE1 · COMPLETED · sponsor: **Venatorx Pharmaceuticals, Inc.** · enrollment: 42 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DRUG:** VNRX-5133
- **DRUG:** VNRX-5022
- **DRUG:** Metronidazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03332732
- **Lead sponsor:** Venatorx Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-24
- **Primary completion:** 2017-12-20
- **Final completion:** 2017-12-20
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03332732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03332732, "VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03332732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*